A
Arianna Sonaglia
Researcher at University of Udine
Publications - 13
Citations - 289
Arianna Sonaglia is an academic researcher from University of Udine. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 4, co-authored 5 publications receiving 190 citations.
Papers
More filters
Journal ArticleDOI
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.
Luca Quartuccio,Arianna Sonaglia,Dennis McGonagle,Martina Fabris,Maddalena Peghin,Davide Pecori,Amato De Monte,Tiziana Bove,Francesco Curcio,Flavio Bassi,Salvatore De Vita,Carlo Tascini +11 more
TL;DR: Higher inflammatory markers, more infections and worse outcomes characterized ventilated TOCI cases compared to ward based TOCi, which suggests that therapy time in anti-cytokine randomized trials will be key.
Journal ArticleDOI
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6.
Luca Quartuccio,Arianna Sonaglia,Davide Pecori,Maddalena Peghin,Martina Fabris,Carlo Tascini,Salvatore De Vita +6 more
TL;DR: The most serious COVID‐19 deriving from severe acute respiratory syndrome coronavirus 2 causes a cytokine release storm and it is associated with worse outcomes, and blocking IL‐6 preliminarily resulted in the improvement of this hyperinflammatory state.
Journal ArticleDOI
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Luca Quartuccio,Martina Fabris,Arianna Sonaglia,Maddalena Peghin,Rossana Domenis,Adriana Cifù,Francesco Curcio,Carlo Tascini +7 more
TL;DR: IL-6, M-CSF, sIL-2Rα, and HGF are possibly involved in the main biological processes of severe COVID-19, mirroring the level of systemic hyperinflammatory state, thelevel of lung inflammation, and the severity of organ damage.
Posted ContentDOI
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care.
Luca Quartuccio,Arianna Sonaglia,Dennis McGonagle,Martina Fabris,Maddalena Peghin,Davide Pecori,Amato De Monte,Tiziana Bove,Francesco Curcio,Flavio Bassi,Salvatore De Vita,Carlo Tascini +11 more
TL;DR: Higher inflammatory markers, more superimposed infections and worse outcomes characterized ventilated TOCI cases compared to ward based TOCi therapy, and this study suggests that therapy time in anti-cytokine randomized clinical trials will be key.
Journal ArticleDOI
Post-COVID-19 Arthritis and Sacroiliitis: Natural History with Longitudinal Magnetic Resonance Imaging Study in Two Cases and Review of the Literature.
Donatella Colatutto,Arianna Sonaglia,Alen Zabotti,Lorenzo Cereser,Rossano Girometti,Luca Quartuccio +5 more
TL;DR: In this paper, the authors report the natural history of sacroiliac inflammatory involvement in two females who developed COVID-19 infection with mild flu-like symptoms after the infection.